315 related articles for article (PubMed ID: 12852794)
1. C-reactive protein: a novel marker of cardiovascular risk.
Shah SH; Newby LK
Cardiol Rev; 2003; 11(4):169-79. PubMed ID: 12852794
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
Koenig W
Ital Heart J; 2001 Mar; 2(3):157-63. PubMed ID: 11305526
[TBL] [Abstract][Full Text] [Related]
3. [C-reactive protein in cardiovascular risk evaluation].
Fabijanić D; Banić M; Kardum D
Lijec Vjesn; 2006; 128(5-6):167-74. PubMed ID: 16910418
[TBL] [Abstract][Full Text] [Related]
4. High sensitivity C-reactive protein in cardiovascular risk assessment. CRP mania or useful screening?
Sellmayer A; Limmert T; Hoffmann U
Int Angiol; 2003 Mar; 22(1):15-23. PubMed ID: 12771851
[TBL] [Abstract][Full Text] [Related]
5. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
6. How to use the C-reactive protein in cardiac disease?
Ursella S; Mazzone M; Portale G; Testa A; Pignataro G; Covino M; Fenici P; Gasbarrini GB; Gentiloni Silveri N
Minerva Cardioangiol; 2005 Feb; 53(1):59-68. PubMed ID: 15788980
[TBL] [Abstract][Full Text] [Related]
7. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
[TBL] [Abstract][Full Text] [Related]
8. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.
Mitra B; Panja M
J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009
[TBL] [Abstract][Full Text] [Related]
9. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
Koenig W
Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
[TBL] [Abstract][Full Text] [Related]
10. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
Li JJ; Fang CH
Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein: a new risk assessment tool for cardiovascular disease.
Clearfield MB
J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein: a nontraditional serum marker of cardiovascular risk.
de Ferranti SD; Rifai N
Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210
[TBL] [Abstract][Full Text] [Related]
15. Role of C-reactive protein in coronary risk reduction: focus on primary prevention.
Gotto AM
Am J Cardiol; 2007 Mar; 99(5):718-25. PubMed ID: 17317380
[TBL] [Abstract][Full Text] [Related]
16. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
Wilson AM; Ryan MC; Boyle AJ
Int J Cardiol; 2006 Jan; 106(3):291-7. PubMed ID: 16337036
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
Ridker PM
Am Heart J; 2004 Jul; 148(1 Suppl):S19-26. PubMed ID: 15211329
[TBL] [Abstract][Full Text] [Related]
18. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of C-reactive protein and troponin T level in patients with unstable angina pectoris].
Tanaka H; Tsurumi Y; Kasanuki H
J Cardiol; 2006 Apr; 47(4):173-9. PubMed ID: 16637251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
